[International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012]
- PMID: 25418900
[International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia 2012]
Abstract
Kidney tumours form a broad spectrum of distinguished histopathological and molecular genetic entities. The last WHO classification is dated to 2004. Current classification has been published in October 2013 by ISUP (International Society of Urological Pathology). There were 5 new epithelials tumours: tubulocystic renal cell carcinoma (RCC), acquired cystic disease-associated RCC, clear cell (tubulo-)papillary RCC, the MiT family translocation RCCs (in particular t(6;11) RCC), and hereditary leiomyomatosis RCC syndrome-associated RCC. Another 3 subtypes of RCC were added as "provisional" entities: thyroid-like follicular RCC; succinate dehydrogenase B deficiency-associated RCC; and ALK translocation RCC. Modifications were performed in already existing entities: multicystic clear cell RCC (formerly multilocular cystic RCC) is newly included as a subcategory of clear cell RCC with low malignant potential. Oncocytic papillary RCC (PRCC) has not been recognized as a distinctive subcategory of PRCC yet. Hybrid oncocytic-chromophobe tumour was placed within the chromophobe RCC category. Recent advances related to collecting duct carcinoma, renal medullary carcinoma, and mucinous spindle cell and tubular RCC were elucidated. Outside of the epithelial category, current approach to our understanding of angiomyolipoma, including the epithelioid variant and angiomyolipoma with epithelial cysts was clarified. Cystic nephroma and mixed epithelial and stromal tumour were considered as a spectrum of one entity. Synovial sarcoma was placed within the sarcoma group. The new classification is to be referred to as the International Society of Urological Pathology Vancouver Classification of Renal Neoplasia.
Similar articles
-
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia.Am J Surg Pathol. 2013 Oct;37(10):1469-89. doi: 10.1097/PAS.0b013e318299f2d1. Am J Surg Pathol. 2013. PMID: 24025519
-
[Vancouver classification of renal tumors: Recommendations of the 2012 consensus conference of the International Society of Urological Pathology (ISUP)].Pathologe. 2015 May;36(3):310-6. doi: 10.1007/s00292-014-2030-z. Pathologe. 2015. PMID: 25398389 German.
-
Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference.Urology. 2014 May;83(5):969-74. doi: 10.1016/j.urology.2014.02.004. Epub 2014 Mar 22. Urology. 2014. PMID: 24661331
-
The evolving classification of renal cell neoplasia.Semin Diagn Pathol. 2015 Mar;32(2):90-102. doi: 10.1053/j.semdp.2015.02.002. Epub 2015 Feb 4. Semin Diagn Pathol. 2015. PMID: 25753529 Review.
-
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.Eur Urol. 2016 Jul;70(1):93-105. doi: 10.1016/j.eururo.2016.02.029. Epub 2016 Feb 28. Eur Urol. 2016. PMID: 26935559 Review.
Cited by
-
The prognostic value of ephrin type-A2 receptor and Ki-67 in renal cell carcinoma patients: An Immunohistochemical and Bioinformatical Approach; A STROBE - compliant article.Medicine (Baltimore). 2020 May;99(19):e20191. doi: 10.1097/MD.0000000000020191. Medicine (Baltimore). 2020. PMID: 32384514 Free PMC article.
-
DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway.Onco Targets Ther. 2020 Feb 13;13:1321-1330. doi: 10.2147/OTT.S239407. eCollection 2020. Onco Targets Ther. 2020. PMID: 32103999 Free PMC article.
-
Tr-KIT/c-KIT ratio in renal cell carcinoma.Mol Biol Rep. 2019 Oct;46(5):5287-5294. doi: 10.1007/s11033-019-04985-3. Epub 2019 Jul 24. Mol Biol Rep. 2019. PMID: 31342295
-
Decreased expression of VPS33B correlates with disease progression and unfavorable prognosis in renal cell carcinoma.Int J Clin Exp Pathol. 2019 Mar 1;12(3):835-842. eCollection 2019. Int J Clin Exp Pathol. 2019. PMID: 31933891 Free PMC article.
-
Association of Abl interactor 2, ABI2, with platelet/lymphocyte ratio in patients with renal cell carcinoma: A pilot study.Int J Exp Pathol. 2020 Jun;101(3-4):87-95. doi: 10.1111/iep.12349. Epub 2020 Jun 4. Int J Exp Pathol. 2020. PMID: 32496656 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical